These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 20132195

  • 1. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
    Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U, Bastian PJ, Volkmer BG, Kassouf W, Novara G, Fritsche HM, Izawa JI, Ficarra V, Lerner SP, Sagalowsky AI, Schoenberg MP, Kamat AM, Dinney CP, Lotan Y, Marberger MJ, Fradet Y.
    BJU Int; 2010 May; 105(10):1402-12. PubMed ID: 20132195
    [Abstract] [Full Text] [Related]

  • 2. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
    Bolenz C, Herrmann E, Bastian PJ, Michel MS, Wülfing C, Tiemann A, Buchner A, Stief CG, Fritsche HM, Burger M, Wieland WF, Höfner T, Haferkamp A, Hohenfellner M, Müller SC, Ströbel P, Trojan L.
    BJU Int; 2010 Aug; 106(4):493-9. PubMed ID: 20067452
    [Abstract] [Full Text] [Related]

  • 3. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.
    J Clin Oncol; 2005 Sep 20; 23(27):6533-9. PubMed ID: 16116151
    [Abstract] [Full Text] [Related]

  • 4. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O'Donnell MA, Joudi FN.
    BJU Int; 2009 Feb 20; 103(4):475-9. PubMed ID: 18990174
    [Abstract] [Full Text] [Related]

  • 5. The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis.
    Canter D, Guzzo T, Resnick M, Magerfleisch L, Sonnad S, Bergey M, Tomazewski J, Vaughn D, Van Arsdalen K, Malkowicz B.
    BJU Int; 2008 Sep 20; 102(8):952-7. PubMed ID: 18485042
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.
    J Urol; 2006 Dec 20; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.
    Palmieri F, Brunocilla E, Bertaccini A, Guidi M, Pernetti R, Morselli-Labate AM, Martorana G.
    Anticancer Res; 2010 Jul 20; 30(7):2973-6. PubMed ID: 20683041
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
    Quek ML, Stein JP, Nichols PW, Cai J, Miranda G, Groshen S, Daneshmand S, Skinner EC, Skinner DG.
    J Urol; 2005 Jul 20; 174(1):103-6. PubMed ID: 15947587
    [Abstract] [Full Text] [Related]

  • 9. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec 20; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

  • 10. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
    Lotan Y, Bagrodia A, Passoni N, Rachakonda V, Kapur P, Arriaga Y, Bolenz C, Margulis V, Raj GV, Sagalowsky AI, Shariat SF.
    Eur Urol; 2013 Sep 20; 64(3):465-71. PubMed ID: 23571005
    [Abstract] [Full Text] [Related]

  • 11. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec 20; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 12. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
    Rink M, Hansen J, Cha EK, Green DA, Babjuk M, Svatek RS, Xylinas E, Tagawa ST, Faison T, Novara G, Karakiewicz PI, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Comploj E, Tilki D, Bastian PJ, Chun FK, Dahlem R, Scherr DS, Shariat SF.
    BJU Int; 2013 Jan 20; 111(1):74-84. PubMed ID: 22809039
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J, Park S, Song C, Doo C, Cho YM, Ahn H, Kim CS.
    Urology; 2007 Aug 20; 70(2):257-62. PubMed ID: 17826485
    [Abstract] [Full Text] [Related]

  • 14. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E, Stöter E, van Ophoven A, Bierer S, Bolenz C, Hertle L, Wülfing C.
    Int J Urol; 2008 Jul 20; 15(7):607-11. PubMed ID: 18462352
    [Abstract] [Full Text] [Related]

  • 15. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D, Shariat SF, Lotan Y, Rink M, Karakiewicz PI, Schoenberg MP, Lerner SP, Sonpavde G, Sagalowsky AI, Gupta A.
    BJU Int; 2013 Jun 20; 111(8):1215-21. PubMed ID: 23181623
    [Abstract] [Full Text] [Related]

  • 16. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M, Xylinas E, Chromecki TF, Breinl E, Svatek RS, Donner G, Tagawa ST, Tilki D, Bastian PJ, Karakiewicz PI, Volkmer BG, Novara G, Joual A, Faison T, Sonpavde G, Daneshmand S, Lotan Y, Scherr DS, Shariat SF.
    Eur Urol; 2013 Nov 20; 64(5):837-45. PubMed ID: 22877503
    [Abstract] [Full Text] [Related]

  • 17. Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy.
    Xylinas E, Rink M, Novara G, Green DA, Clozel T, Fritsche HM, Guillonneau B, Lotan Y, Kassouf W, Tilki D, Babjuk M, Karakiewicz PI, Montorsi F, Abdennabi J, Trinh QD, Svatek RS, Scherr DS, Zerbib M, Shariat SF.
    Ann Surg Oncol; 2013 Mar 20; 20(3):1027-34. PubMed ID: 23099729
    [Abstract] [Full Text] [Related]

  • 18. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K, Poulsen AL.
    J Urol; 2007 Oct 20; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer.
    Hugen CM, Polcari AJ, Fitzgerald MP, Dauw C, Flanigan RC, Quek ML.
    J Surg Oncol; 2010 Sep 15; 102(4):334-7. PubMed ID: 20607757
    [Abstract] [Full Text] [Related]

  • 20. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF.
    J Urol; 2010 May 15; 183(5):1757-63. PubMed ID: 20299059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.